When comparing our findings with those from other studies, it is evident that the adoption of PSMA PET/CT in Iraq follows similar patterns observed in other regions, particularly in terms of its high sensitivity and specificity in detecting prostate cancer metastases. The gene discussed is FOLH1; the disease is prostate cancer.